News

Aciex Therapeutics and Portola Pharmaceuticals have entered into a collaborative agreement to develop drugs for the treatment of topical ophthalmic diseases, according to the latest press release.

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Ocular surface stem cell transplantation (OSST) patients should be closely monitored for rejection and compliance with immunosuppression.

Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in keratoconus patients, states a recent paper.

Real world experience of leading ophthalmic products - issue 2

Volume and area changes in retinal pigment epithelial detachments (PEDs) could indicate the need for retreatment in eyes undergoing SD-OCT guided anti-VEGF therapy.

Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims a recent investigation.

Is there a correlation between choroidal thickness and certain types of glaucoma

US pachymetry offers no advantage over optical noncontact methods, according to Dr Savini

The thickness of several different layers of the retina is reduced in eyes with glaucoma

New clinical approach targeted to early detection

Modifications of haptic design yields benefits

Technology appears to be useful, necessary complement to cross-sectional B-scans

Study shows reproducibility with devices dedicated to standardizing capsulorhexis

Corneal biomechanical stability is better, less affected by flapless refractive procedure

Comparative data demonstrates good agreement between devices

Doube optimization for improved solutions

A round-up of the latest ophthalmic products

Study outcomes demonstrate feasibility of technique as primary treatment

The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable.

Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS study.

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

Low doses of clobetasone butyrate drops are safe and effective for Sj?gren syndrome (SS), claims an investigation.

Bevacizumab could play a role in treating Coats' disease, claims a recent study.

Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery, according to a recent study.

Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary open-angle glaucoma, reveals a study in the Journal of Glaucoma.

Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic artery chemosurgery can effectively treat retinoblastoma refractory without ocular side effects, claims a study.

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

Ivantis announced the completion of financing $27 million for a novel glaucoma procedure at the Glaucoma Research Foundation's latest meeting.

Geuder has announced its support for ophthalmic clinic CEPRECE, based in Cusco, Peru.